--- title: ECIO 2026 Basel preview - Ablation on our home field description: CASCINATION highlights the relevant tumor ablation topics at ECIO 2026 in Basel, Switzerland image: https://www.cascination.com/hubfs/ECIO%20Banner%202026.png --- Tuesday, 31 March 2026 # ECIO 2026 Basel preview - Ablation on our home field The CASCINATION team is eager to embark on this springs biggest IR event - and finally, in our home country! We are happy to take on the role as the (unofficial) host company. ![ECIO Banner 2026](https://www.cascination.com/hs-fs/hubfs/ECIO%20Banner%202026.png?width=4200&height=1440&name=ECIO%20Banner%202026.png) As we have grown over the years - so does our booth space. Once again, we will have two CAS-One IR systems present to give plenty of rich, hands-on experiences to interested physicians. We did this at CIRSE Barcelona last year, after the previous ECIO and CIRSE we had to force people to wait to try out CAS-One IR for themselves. This year will feature our biggest release since our Ablation Confirmation software, AblaSure. We are bringing Automatic Fusion to CAS-One IR with AblaFuse. No longer will organ movement - for whatever reason - or tissue deformation disrupt your plan, your needle verification, or most importantly, your ablation confirmation. With little physician input, CAS-One IR will fuse images to ensure procedural accuracy is kept in all phases of the Quality Ablation workflow. There are many more features which bring more value to percutaneous tumor treatments - Come by to see it for yourself - you can even bring a dataset (pre and post contrast enhanced CT) if you want to test AblaFuse yourself. See our full [landing page dedicated to the release here](https://www.cascination.com/cas-one-ir-4.4?hsLang=en) Last year there were [10+ abstracts ](https://www.cascination.com/en/news/ecio-2025-rotterdam-recap?hsLang=en) presented featuring the use of CAS-One IR. This year there are multiple and we want to highlight our favorite: [A CT-guided MWA of 3 perihepatic HCC recurrences after liver transplantation using hydrodissectio and navigation](https://programme.ecio2026.cirse.org/ecio2026/crs/ct-guided-microwave-ablation-of-three-perihepatic-hcc-recurrences-after-liver-transplantation-using-hydrodissection-and-navigation) Every year we analyze the agenda and call out what we believe to be the most interesting topics - please see below for our guide to "can't miss" sessions focused on ablation. From IR on the front likes of the Ukraine war, to proving economic value, to of course the specifics of ablation in certain tumors or organs, there is a lot to hear and see at this years ECIO.   # **Monday April 27th** **CF 211 – Pushing the boundaries in HCC management: new horizons in… **8:30-10 Auditorium 1 211.1 … percuntanoues ablation - M. Pech 211.6 …artificial intelligence – F. Gomez Munoz **CFF 221 - Mastering local treatment of metastatic colorectal cancer** 10:30-12:00 – Auditorium 1 221.2 From OR to IR to hybrid – A. Fretland 221.3 Implementing best practice in liver ablation: planning, monitoring and confirmation – B. Odisio 221.4 IRE, cryo, Y90 and SBRT for CRLM: when heat is not the answer – A. Kovacs 221.5 Colorectal liver mets: How big is too big? How many is too many? - R. Bale **CFF 222 – Defining success in renal IO: outcomes that drive practice ** 10:30-12:00 Auditorium 2 222.1 Ablation techniques: what the data reveal – O. Moschovaki-Zeiger 222.2 Percutaneous ablation of T1a: standard of care? – O. Graumann **CF 243 – Shaping the future of IR: leadership, collaboration, and training across borders **15:00-16:30 Auditorium 3 243.1 Doing more with less: how to deal with fixed budgets and rising demands – M. van den Bosch 243.7 Frontline IR: delivering care during the war in Ukraine – O. Korshak **CF 252 – Setting standards, building evidence and driving impact in IO **17:00-18:00 Auditorium 2 252.1 Defining evidence standards in IO: choosing the right weapon for the right fight – H. Verkooijen 252.2 Beyond the numbers: defining “enough” in IO evidence generation – T. Gade 252.3 From data to decision-making: writing for policy and economic impact – M. Burgmans 252.4 Value over volume: when do we need health economic assessments? – M. Lamotte   # **Tuesday April 28th ** **CF 312 – Spinal metastases: multidisciplinary management – **8:30-10:00 Auditorium 2 312.3 Why ablation may be advantageous compared to radiation therapy? R. Cazzato 312.4 Can ablation provide more than "simple" pain relief? J. Jennings **SP 313 – Thermal and non-thermal liver tumour ablation **– 8:30-10:00 Auditorium 3 313.1 A1 ablative margins in colorectal liver metastases: defining when to re-ablate using volume of insufficient coverage – an international multicenter study – I. Paolucci 313.2 Thermal ablation versus surgical resection for intermediate-size (3-5 cm) colorectal liver metastases: results from the Amsterdam Colorectal Liver Met Registry (AmCORE) – M. Dijkstra 313.3 Percutaneous microwave ablation of liver tumors: correspondence of the predicted ablation zone and the actual ablation zone – G. Van Erp   # **Wednesday April 29th ** **CF 412 – Management of extra-spinal bone metastases – **8:30-10:00 Auditorium 2 412.4 Expected results of ablation in palliative and curative scenarios – D. Filippiadis **CF 422 – What can the interventional radiologist do in the treatment of non-colorectal liver metastases? **– 10:30-12:00 Auditorium 2 422.1 Neuroendocrine tumours – J. Ricke 422.2 Melanoma – M. Soulen 422.3 Breast – G. Narayanan 422.4 GIST and other primary gastrointestinal tumours – J. Erinjeri 422.5 Sarcoma – R. Iezzi **CF 423 – Cancer as a chronic disease – **10:30-12:00 Auditorium 3 423.1 Why I chose the minimally invasive option: a patient's perspective – C. van der Geest 423.2 Life with chronic cancer: a patient’s perspective – S. Patton **EM 442 – ECIO meets E-AHPBA: Cut or burn? When surgeons and interventional oncologists team up –** 15:00-16:30 Auditorium 2 442.2 From collision to coalition: when ego meets evidence in the management of colorectal liver mets – A. Fretland **CFF 443 – Meet the PI – **15:00-16:30 Auditorium 3 443.1 The Dutch Model – M. Meijerink 443.2 CRYORL – R. Cazzato 443.4 COLLISION XL – P. van Rossum 443.7 Impact of ablation margin size on long-term outcomes after MWA of CRLM: results from the prospective CIEMAR registry – P. Pereira 443.8 The POLAR trial - A Phase I study of tumour cryOabLAtIon in combination with ipilimumab and nivolumab in front-line treatment of metastatic Renal cell carcinoma – J. Brandon **CF 452 – Smart tools, smarter IO - **17:00-18:30 Auditorium 2 452.1 Robotic and non-robotic tumour ablation and biopsy-guiding systems – R. Bale 452.2 AI-guided precision in tumour interventions from percutaneous to endovascular approaches – J. Martinez Rodrigo 452.3 Augmented reality for image-guided procedures in IO – M. van Strijen 452.5 IR suite of the future: Integrating AI, imaging, and data for real-time decision-making in IO – A. Najafi       Let the coundown continue! Looking forward to seeing you there.       ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "Ted Farwell", "url" : "https://www.cascination.com/en/news/author/ted-farwell" }, "dateModified" : "2026-04-20T09:25:28.121Z", "datePublished" : "2026-03-31T18:08:49.000Z", "headline" : "ECIO 2026 Basel preview - Ablation on our home field", "image" : [ "https://www.cascination.com/hubfs/ECIO%20Banner%202026.png" ], "mainEntityOfPage" : { "@id" : "https://www.cascination.com/en/news/ecio-2026-basel-preview-ablation-on-our-home-field", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://www.cascination.com/hubfs/CASCINATION_Logo_2021_Website.png" }, "name" : "CASCINATION AG" } } ``` ```json { "@context" : "https://schema.org", "@type" : "VideoObject", "contentUrl" : "https://4661825.fs1.hubspotusercontent-na1.net/hubfs/4661825/video_assets/210246329754/inherited/web_optimized.mp4", "dateModified" : "2026-03-31T09:15:50.445Z", "duration" : "PT27S", "height" : 1080, "name" : "AblaFuse", "thumbnailUrl" : "https://api-na1.hubspot.com/filemanager/api/v3/files/thumbnail-redirect/210246329754?portalId=4661825&size=medium", "uploadDate" : "2026-03-31T09:15:32.751Z", "width" : 1920 } ```